A final trial analysis shows the company’s vaccine is 95% effective with no safety concerns, and it will seek FDA emergency use ‘within days’

a-final-trial-analysis-shows-the-company’s-vaccine-is-95%-effective-with-no-safety-concerns,-and-it-will-seek-fda-emergency-use-‘within-days’

A final analysis of the Phase 3 trial of Pfizer’s coronavirus vaccine shows it was 95% effective in preventing infections, even in older adults, and caused no serious safety concerns, the company said Wednesday.

Times2 Desk
Latest News Headlines: Times2 covers Latest India News, Top Today's Breaking News on Business, India, World, Politics, Entertainment and Sports …